Evidence map›Paper›PMID 23225497›Full record

ArticleAmerican journal of medical genetics. Part A2013

Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion.

Kimberly A Aldinger, Jillene Kogan, Virginia Kimonis, Bridget Fernandez, Denise Horn, Eva Klopocki, Brian Chung, Annick Toutain, Rosanna Weksberg, Kathleen J Millen and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Reduced brain volume and white matter alterations in Shank3-deficient rats.Autism research : official journal of the International Society for Autism Research · 2021
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Severe white matter damage in SHANK3 deficiency: a human and translational study.Annals of clinical and translational neurology · 2020
    Article
  18. Article
  19. Frontiers in neural circuits · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 4 countries.

Kimberly A AldingerCommittee on Neurobiology, The University of Chicago, Chicago, IL, USA.
Jillene Kogan
Virginia Kimonis
Bridget Fernandez
Denise Horn
Eva Klopocki
Brian Chung
Annick Toutain
Rosanna Weksberg
Kathleen J Millen
A James Barkovich
William B Dobyns
Charité - Universitätsmedizin Berlin · DEHospital for Sick Children · CABretonneau Hospital · FRCincinnati Children's Hospital Medical Center · USMemorial University of Newfoundland · CASeattle Children's Hospital · USUniversity of California, Irvine · USUniversity of California, San Francisco · USUniversity of Chicago · USUniversity of Washington · US

Funding

De novo copy number variation and gene discovery in human brain malformationsR01NS058721 · NINDS · UNIVERSITY OF CHICAGO · PI ARGILLI, EMANUELA · 2008 to 2025
$10.9M
The Genetic Basis of Mid-Hindbrain MalformationsR01NS050375 · NINDS · UNIVERSITY OF MINNESOTA · PI DOBYNS, WILLIAM B. · 2005 to 2019
$9.9M
Roles of Zic Genes in Vertebrate Hindbrain DevelopmentR01NS050386 · NINDS · UNIVERSITY OF CHICAGO · PI MILLEN, KATHLEEN JOYCE · 2004 to 2010
$2.1M
Autism Speaks AS3587NINDS NIH HHS R01 NS050375NINDS NIH HHS R01 NS050386NINDS NIH HHS R01 NS058721
6 · The paper itself

Abstract

The 22q13.3 deletion causes a neurodevelopmental syndrome, also known as Phelan-McDermid syndrome (MIM #606232), characterized by developmental delay and severe delay or absence of expressive speech. Two patients with hemizygous chromosome 22q13.3 telomeric deletion were referred to us when brain-imaging studies revealed cerebellar vermis hypoplasia (CBVH). To determine whether developmental abnormalities of the cerebellum are a consistent feature of the 22q13.3 deletion syndrome, we examined brain-imaging studies for 10 unrelated subjects with 22q13 terminal deletion. In seven cases where the availability of DNA and array technology allowed, we mapped deletion boundaries using comparative intensity analysis with single nucleotide polymorphism (SNP) microarrays. Approximate deletion boundaries for three additional cases were derived from clinical or published molecular data. We also examined brain-imaging studies for a patient with an intragenic SHANK3 mutation. We report the first brain-imaging data showing that some patients with 22q13 deletions have severe posterior CBVH, and one individual with a SHANK3 mutation has a normal cerebellum. This genotype-phenotype study suggests that the 22q13 deletion phenotype includes abnormal posterior fossa structures that are unlikely to be attributed to SHANK3 disruption. Other genes in the region, including PLXNB2 and MAPK8IP2, display brain expression patterns and mouse mutant phenotypes critical for proper cerebellar development. Future studies of these genes may elucidate their relationship to 22q13.3 deletion phenotypes.

Indexed as

Adaptor Proteins, Signal TransducingAdolescentAutistic DisorderCerebellumChildChild, PreschoolChromosome DeletionChromosome DisordersChromosome MappingChromosomes, Human, Pair 22Developmental DisabilitiesGenetic Association StudiesGenetic LociGenotypeHumansImage Processing, Computer-AssistedAdaptor Proteins, Signal TransducingMAPK8IP2 protein, humanNerve Tissue ProteinsSHANK3 protein, human

Identifiers

PMID23225497
PMCPMC3733662
OpenAlexW1985679776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.